Literature DB >> 22975648

Prognostic value of postoperative CA19-9 normalization in patients with advanced gastric cancer.

Oh Kyoung Kwon1, Wansik Yu, Hoyoung Chung.   

Abstract

BACKGROUND/AIMS: CA19-9 is known to have positive correlation with depth of invasion, nodal involvement, and peritoneal metastasis in gastric adenocarcinoma. In patients with high preoperative CA19-9 serum levels who underwent curative gastrectomy, we evaluated the prognostic impact of postoperative normalization of CA 19-9.
METHODOLOGY: Among 1,439 patients who underwent curative gastrectomy for advanced gastric adenocarcinoma, data of 102 patients with advanced gastric adenocarcinoma whose preoperative serum CA19-9 level was higher than cutoff value (37 U/mL) were reviewed. If serum CA19-9 level had fallen below 37 U/mL at 6 months after surgery, the CA19-9 level was considered normalized.
RESULTS: CA19-9 levels were normalized in 79 patients but not in 23 patients. There were statistically significant differences in prognosis according to depth of invasion, presence of lymph node metastasis, extent of gastric resection, and postoperative CA19-9 normalization on univariate analyses. Multivariate analysis revealed that pathological lymph node metastasis (p<0.001) and postoperative CA19-9 normalization were independent prognostic factors (p=0.001).
CONCLUSIONS: In patients with advanced gastric adenocarcinoma who underwent curative gastric resection, postoperative normalization of CA19-9 can be a surrogate for potentially curative surgical treatment and can be used as a good prognostic factor.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22975648     DOI: 10.5754/hge12585

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  14 in total

1.  High level of preoperative carbohydrate antigen 19-9 is a poor survival predictor in gastric cancer.

Authors:  A Ra Choi; Jun Chul Park; Jie-Hyun Kim; Sung Kwan Shin; Sang Kil Lee; Yong Chan Lee; Jae Bock Chung
Journal:  World J Gastroenterol       Date:  2013-08-28       Impact factor: 5.742

2.  Prognostic Significance of Platelet-Based Inflammatory Indicators in Patients with Gastric Cancer.

Authors:  Hiroaki Saito; Yusuke Kono; Yuki Murakami; Yuji Shishido; Hirohiko Kuroda; Tomoyuki Matsunaga; Yoji Fukumoto; Tomohiro Osaki; Keigo Ashida; Yoshiyuki Fujiwara
Journal:  World J Surg       Date:  2018-08       Impact factor: 3.352

3.  Influence of prognostic nutritional index and tumor markers on survival in gastric cancer surgery patients.

Authors:  Hiroaki Saito; Yusuke Kono; Yuki Murakami; Hirohiko Kuroda; Tomoyuki Matsunaga; Yoji Fukumoto; Tomohiro Osaki
Journal:  Langenbecks Arch Surg       Date:  2017-03-15       Impact factor: 3.445

4.  An Alternative Method for Screening Gastric Cancer Based on Serum Levels of CEA, CA19-9, and CA72-4.

Authors:  Junxiu Yu; Wanlei Zheng
Journal:  J Gastrointest Cancer       Date:  2018-03

5.  Differences and correlation of serum CEA, CA19-9 and CA72-4 in gastric cancer.

Authors:  Junxiu Yu; Shuguang Zhang; Bingbo Zhao
Journal:  Mol Clin Oncol       Date:  2015-12-15

6.  A Novel Electrochemical Microfluidic Chip Combined with Multiple Biomarkers for Early Diagnosis of Gastric Cancer.

Authors:  Yao Xie; Xiao Zhi; Haichuan Su; Kan Wang; Zhen Yan; Nongyue He; Jingpu Zhang; Di Chen; Daxiang Cui
Journal:  Nanoscale Res Lett       Date:  2015-12-10       Impact factor: 4.703

7.  Prognostic values of normal preoperative serum cancer markers for gastric cancer.

Authors:  Fan Feng; Li Sun; Zhen Liu; Shushang Liu; Gaozan Zheng; Guanghui Xu; Man Guo; Xiao Lian; Daiming Fan; Hongwei Zhang
Journal:  Oncotarget       Date:  2016-09-06

8.  CA19-9-producing esophageal adenocarcinoma originating from the esophageal cardia of the mid-thoracic esophagus: a case report.

Authors:  Naoki Kuwayama; Isamu Hoshino; Hisashi Gunji; Takeshi Kurosaki; Toru Tonooka; Hiroaki Soda; Itaru Sonoda; Ryotaro Eto; Nobuhiro Takiguchi; Yoshihiro Nabeya; Makiko Itami; Wataru Takayama
Journal:  Surg Case Rep       Date:  2021-07-15

Review 9.  Classic tumor markers in gastric cancer. Current standards and limitations.

Authors:  Călin Căinap; Viorica Nagy; Alexandra Gherman; Sanziana Cetean; Istvan Laszlo; Anne-Marie Constantin; Simona Căinap
Journal:  Clujul Med       Date:  2015-04-15

Review 10.  Clinicopathologic and Prognostic Value of Serum Carbohydrate Antigen 19-9 in Gastric Cancer: A Meta-Analysis.

Authors:  Yong-xi Song; Xuan-zhang Huang; Peng Gao; Jing-xu Sun; Xiao-wan Chen; Yu-chong Yang; Cong Zhang; Hong-peng Liu; Hong-chi Wang; Zhen-ning Wang
Journal:  Dis Markers       Date:  2015-10-21       Impact factor: 3.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.